Back to Search Start Over

DNA Methylation of CD70 Promoter in Juvenile Systemic Lupus Erythematosus.

Authors :
Keshavarz-Fathi, Mahsa
Sanati, Golshid
Sadr, Maryam
Mohebbi, Bahareh
Ziaee, Vahid
Rezaei, Nima
Source :
Fetal & Pediatric Pathology; Feb 2022, Vol. 41 Issue 1, p58-67, 10p
Publication Year :
2022

Abstract

Epigenetic alterations in pathogenesis of systemic lupus erythematosus (SLE) have gained more attention recently in adults. We assessed the methylation of CD70 promoter, a costimulatory molecule on T cells, in juvenile SLE (JSLE), and compared this to that found in controls and the literature of adult SLE patients. DNA methylation status was evaluated on peripheral blood from JSLE patients and healthy controls. Twenty-five patients with JSLE and 24 healthy controls were compared. JSLE patients had lower unmethylated CpG islands compared to the control group (mean ± SD; 0.78 ± 0.42 vs 10503.80 ± 39796.95). However, the difference was not significant (P-value; 0.22). Despite hypomethylation of CD70 gene promoter in CD4+ T-cells from adult patients with SLE, no statistically significant differences observed in patients with JSLE compared with healthy controls. This may suggest a mechanism different in JSLE patients than in adults. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15513815
Volume :
41
Issue :
1
Database :
Complementary Index
Journal :
Fetal & Pediatric Pathology
Publication Type :
Academic Journal
Accession number :
155083029
Full Text :
https://doi.org/10.1080/15513815.2020.1764681